| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |